
1. Moving the Markets
The all too familiar mantra pushed indexes higher with the S&P conquering the 2,100 level again. Equities rallied because economic outlook is fragile, bond yields are dropping, US manufacturing is extremely weak and suddenly the odds for a December rate hike are heading south. In other words, the markets rallied in the face of poor macro data. It almost seemed as if Wall Street expects another QE announcement by the Fed and not a rate hike. Go figure…
On the other hand, maybe markets just got into the Christmas spirit as all 3 major indexes gained about 1%. Historically, December has been a profitable month for stocks. In the past 100 years, December has ranked No. 1 in performance, posting an average gain of 1.46%, although gains have downsized to 1.37% in the past 20 years, according to Cap IQ.
Investors today seemed pleased with the results of Cyber Monday, which Adobe says is stacking up to be the “largest online sales day in history.” Adobe estimates that online sales yesterday totaled roughly $2.98 billion, a 12% increase over 2014 Cyber Monday sales.
The big event this December, of course, comes on Dec. 16, when the Federal Reserve breaks from its final meeting of the year and is expected to hike interest rates for the first time in nearly a decade. Wall Street is expecting short-term rates, currently pegged near 0%, to be increased by a quarter of a percentage point.
All of our 10 ETFs in the Spotlight followed the major indexes higher as Healthcare (XLV) took the lead by gaining +1.69%. Lagging the group was the Select Dividend ETF (DVY) with +0.74%.


The recent stream of data indicates everything is good enough for the Fed to proceed as planned with a rate-hike in December, said Michael Gapen, Chief US Economist. Although the latest inflation report came in softer than many had expected, it was no surprise; again that was just further softness in core goods prices, being weighed down by a stronger dollar and excess capacity abroad.
JP Morgan Asset Management, the exchange-traded fund issuing arm of the investment bank JP Morgan, recently joined hands with FTSE Russell to leverage their respective capabilities in investment science and index designing.